POLYETHER ETHER KETONE MARKET ANALYSIS

Key Developments

• In March 2023, Victrex PLC's introduction of a new type of implantable PEEK-OPTIMA polymer tailored for use in the production of medical device additives, including fused deposition modeling (FDM) and fused filament fabrication (FFF), marks a significant advancement in the field of medical technology. This specialized polymer offers enhanced properties that make it ideal for applications requiring biocompatibility, durability, and precision. By leveraging this innovative material in manufacturing processes, medical device producers can achieve higher quality, more reliable products that meet stringent regulatory standards and improve patient outcomes.
• In February 2023, Victrex PLC's strategic decision to invest in the expansion of its medical division, Invibio Biomaterial Solutions, by setting up a new product development facility in Leeds, U.K., signifies a significant commitment to advancing the field of biomaterials and medical technology. This expansion initiative is poised to enhance Victrex PLC's capabilities in research, innovation, and product development, enabling the company to further strengthen its position as a leading provider of high-performance biomaterial solutions for medical applications.
• In March 2021, Evonik Industries, a Germany-based specialty chemicals company, launched INFINAM PEEK, a new 3D printable filament based on Polyether Ether Ketone (PEEK). The new ready-to-use polymer filament is ideal for metal replacement in infinite 3D applications and helped the company to expand its product portfolio.
• In January 2020, Yingkou Xingfu Chemical Company Limited, a chemical company in China, and Victrex Hong Kong Limited, a leader in PEEK and PAEK-based polymer solutions, entered into an agreement, to build a manufacturing facility of a new PEEK polymer in Liaoning, China. With this agreement, both companies will be able to cater to their customer demands.